🔗 Visit the ClinicalTrials.gov page for NCT02313272
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data. | Front Oncol | 2015 | 0.92 |
| 2 | Targetable genetic features of primary testicular and primary central nervous system lymphomas. | Blood | 2015 | 0.88 |
| 3 | Trial Watch: Immunotherapy plus radiation therapy for oncological indications. | Oncoimmunology | 2016 | 0.81 |
| 4 | Current clinical trials testing the combination of immunotherapy with radiotherapy. | J Immunother Cancer | 2016 | 0.81 |
| 5 | Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. | Front Oncol | 2016 | 0.78 |
| 6 | Immunotherapy in glioblastoma: emerging options in precision medicine. | CNS Oncol | 2016 | 0.75 |